Atlas FDA

ADEPT ADHESION REDUCTION SOLUTION (4% ICODEXTRIN)

FDA premarket approval P050011/S004 · decided 2013-07-02

Approval details

PMA number
P050011
Supplement
S004
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
ADEPT ADHESION REDUCTION SOLUTION (4% ICODEXTRIN)
Generic name
Barrier, absorbable, adhesion
Applicant
Baxter Healthcare Corp
Date received
2013-06-06
Decision date
2013-07-02
Days to decision
26 days
Decision code
OK30
Product code
MCN
Advisory committee
Obstetrics/Gynecology
Expedited review
No
Location
Mcgaw Park, IL
Statement
REPLACE THE CURRENT PEPTIDOGLYCAN (PG) TEST METHOD WITH A HIGH SENSITIVITY PG (HS-PG) TEST METHOD.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
PrisMax System Version 2 (K190910)Baxter Healthcare Corp2019-07-25
PrisMax Control Unit (K163530)Baxter Healthcare Corp2017-05-03
ULTRAFUSE (K130531)Baxter Healthcare Corp2014-04-08
NEUTRAL LUER ACTIVATED DEVICE (ONE-LINK NEEDLE-FREE IV CONNECTOR) AND EXTENSION SETS (K132734)Baxter Healthcare Corp2013-10-08
LARGE BORE STOPCOCK WITH ROTATING MALE LUER LOCK/LARGE BORE STOPCOCK WITH EXTENSION SET, GANG LARGE BORE STOPCOCK MANIFO (K130245)Baxter Healthcare Corp2013-03-01
INTERLINK SYSTEM BURETROL SOLUTION SETS, INTERLINK SYSTEM BURETROL SOLUTION SETS, CONTINUED, CLEARLINK SYSTEM BURETROL S (K123874)Baxter Healthcare Corp2013-01-10
INTERLINK SYSTEM LEVER LOCK CANNULA WITH CHECK VALVE, SECONDARY MEDICATION SETS, SOLUTION SETS, CONTINU-FLO SOLUTION SET (K123868)Baxter Healthcare Corp2013-01-08
FLOWEASE [SUBCUTANEOUS] INFUSION SET (K121092)Baxter Healthcare Corp2012-06-29